POWERED BY GEMINI 3.0 Pro

Institutional-Grade
Biotech Intelligence

We combine state-of-the-art Generative AI with real-time community consensus to decode the complex world of biotechnology investing.

The Hybrid Engine

Traditional retail research is slow and often outdated. Catalyst Ventures replaces manual analysis with a sovereign AI reporting system.

Our specialized Gemini 3.0 Pro pipeline uses Google Search Grounding to access real-time clinical trial data, SEC filings, and breaking news.

2,500+
Words Per Report
Live
Search Citations
Gemini 3.0 Pro
Logic & Reasoning Core
Search Grounding
Real-Time Verification
Deep Dive Report
Thesis, Risks, Catalysts

Real-Time Intelligence

We don't just write reports. We track the pulse of the market every single second.

Sentiment Engine

Our bots scan thousands of news articles daily, scoring sentiment on a 0-10 scale across Regulatory, Financial, and Scientific dimensions.

News Crawler

Integrated directly with Google News (SerpAPI) and Gemini, we filter noise to deliver only high-impact "Movers" like FDA approvals and M&A.

Live Timeline

Automated event extraction parses years of history into a clean chronological timeline for every company, updated dynamically.

Crowdsourced
Alpha

AI provides the data, but our community provides the wisdom. Join "Thesis Wars" to debate the Bull vs Bear case, earn "Analyst Accuracy" badges, and influence the consensus.

Join the Discussion
Bull Case

Community Validated Upside

Bear Case

Critical Risk Analysis

Analyst Accuracy Score 94%

Track your prediction performance

Ready to Outperform?

Join thousands of biotech investors using sovereign AI to find their next winning trade.

Our Commitment

Catalyst Ventures is a research platform, not an investment advisor. We use advanced technology to aggregate and analyze public data. All investment decisions should be made based on your own due diligence and consultation with qualified professionals.